Literature DB >> 24745611

Identification of novel predictive markers for the prognosis of pancreatic ductal adenocarcinoma.

Bing Jiang1, Yonghong Gu, Yuxiang Chen.   

Abstract

This study demonstrated that klotho gene expression was significantly lower whereas miR-504 and phospho-IGF-1R levels were significantly higher in PDAC than in normal pancreatic tissues. miR-504 level significantly correlated with klotho mRNA and promoter methylation level in PDACs. Loss of Klotho protein expression, klotho promoter hypermethylation, high miR-504 levels, and high phospho-IGF-1R levels significantly correlated with poor survival, high clinical and pathological stages in PDAC patients. The demethylation reagent and miR-504 inhibitor increased klotho gene expression, invasion, and migration in BxPC-3 and Panc-1 cells. Klotho is a tumor suppressor whose expression in PDAC correlated with progression and prognosis of PDAC.

Entities:  

Keywords:  IGF-1 receptor; Pancreatic ductal adenocarcinoma; klotho; methylation; miR-504; prognosis

Mesh:

Substances:

Year:  2014        PMID: 24745611     DOI: 10.3109/07357907.2014.905586

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  6 in total

1.  Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.

Authors:  Yanlei Guan; Ling Chen; Yijun Bao; Chao Pang; Run Cui; Guangyu Li; Jiyuan Liu; Yunjie Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

2.  Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival.

Authors:  Débora R Bublik; Slađana Bursać; Michal Sheffer; Ines Oršolić; Tali Shalit; Ohad Tarcic; Eran Kotler; Odelia Mouhadeb; Yonit Hoffman; Gilad Fuchs; Yishai Levin; Siniša Volarević; Moshe Oren
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-19       Impact factor: 11.205

3.  Down-expression of klotho in canine mammary gland tumors and its prognostic significance.

Authors:  Heaji Chung; Sungin Lee; Geon A Kim; Wan Hee Kim
Journal:  PLoS One       Date:  2022-06-06       Impact factor: 3.752

Review 4.  Klotho and the Treatment of Human Malignancies.

Authors:  Aishani Sachdeva; Jerome Gouge; Christos Kontovounisios; Stella Nikolaou; Alan Ashworth; Kenneth Lim; Irene Chong
Journal:  Cancers (Basel)       Date:  2020-06-23       Impact factor: 6.639

5.  Zinc Gluconate Induces Potentially Cancer Chemopreventive Activity in Barrett's Esophagus: A Phase 1 Pilot Study.

Authors:  M C Valenzano; E Rybakovsky; V Chen; K Leroy; J Lander; E Richardson; S Yalamanchili; S McShane; A Mathew; B Mayilvaganan; L Connor; R Urbas; W Huntington; A Corcoran; S Trembeth; E McDonnell; P Wong; G Newman; G Mercogliano; M Zitin; B Etemad; J Thornton; G Daum; J Raines; A Kossenkov; L Y Fong; J M Mullin
Journal:  Dig Dis Sci       Date:  2020-05-15       Impact factor: 3.199

6.  A Transgenic Model Reveals the Role of Klotho in Pancreatic Cancer Development and Paves the Way for New Klotho-Based Therapy.

Authors:  Tammi Arbel Rubinstein; Inbal Reuveni; Arkadi Hesin; Anat Klein-Goldberg; Hannes Olauson; Tobias E Larsson; Carmela R Abraham; Ella Zeldich; Assumpció Bosch; Miguel Chillón; Kenneth Samuel Hollander; Ayelet Shabtay-Orbach; Gilad W Vainer; Ido Wolf; Tami Rubinek
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.